Hosted on MSN17d
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the deal ...
pharmaphorum3d
MSD buys Irish vaccines plant from WuXi for €500m
MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...
The Irish Times18d
Drug giant MSD buys Wuxi’s Irish vaccines plant in €500m deal
Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 ...
Hosted on MSN18d
MSD acquires WuXi's vaccine facility in Dundalk for €500m
China's WuXi Biologics is to sell its vaccine manufacturing site in Dundalk to MSD Ireland in a €500m deal. The acquisition is expected to be completed in the first half of this year and will ...
Dundalk Democrat13d
MSD Ireland acquisition of WuXi plant in Dundalk welcomed
News that pharmaceutical company MSD Ireland has acquired the WuXi Vaccines manufacturing facility in Dundalk has been ...
Independent.ie19d
MSD buy out WuXi Vaccines’ Dundalk plant in €500m deal
The pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American company says that in addition to the 150 jobs at the Dundalk facility ...
The Business Journals4d
WuXi moves ahead with new $510M campus in Delaware despite sale of Navy Yard operations
WuXi STA expects to hire about 500 people in the coming years to support Phase 1 of the manufacturing campus. A Chinese pharmaceutical company is moving forward with plans to build a massive $510 ...
RTE Online18d
MSD Ireland agrees deal to buy WuXi Vaccines' Dundalk site
Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its long-term plans in Ireland. MSD said the deal is worth €500m and ...
Seeking Alpha3d
WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade)
My rating upgrade for WuXi Biologics to a Buy has taken into consideration its latest corporate move and business disclosures. The sale of its European manufacturing facility will throw up margin ...
Yahoo Finance12d
WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)
SHANGHAI, Jan. 12, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences ...
Yahoo Finance17d
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...